Status:
UNKNOWN
Synovial Fluid Biomarkers Pre and Post Hymovis Knee Injection
Lead Sponsor:
National Jewish Health
Collaborating Sponsors:
Fidia Pharma USA Inc.
Conditions:
Knee Osteoarthritis
Eligibility:
All Genders
21-80 years
Brief Summary
This NJH Investigator Initiated Study funded by Fidia will prospectively perform 2 ultrasound (US) guided knee aspirations in patients with knee osteoarthritis using a pneumatic compressive device (Kn...
Detailed Description
50 Subjects between 21-80 years with a BMI \< 40 with mild to moderate knee osteoarthritis on x ray (KL grade II or III) will have a ultrasound guided arthrocentesis with an external pneumatic compres...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Mild to moderate knee osteoarthritis on x ray
- age 21-80
- Exclusion Criteria
- pregnant
- BMI \> 40
- history of systemic immune disorders
- knee arthroplasty with replacement
- knee infection or surgery within 1 year
- glucocorticoid injection within 3 months inability to ambulate for 6 minutes without walking assistive devices
- unable to provide informed consent
- patients with a clinical contra-indication for an arthrocentesis or adverse reaction to prior intra-articular lidocaine or HA injections.
Exclusion
Key Trial Info
Start Date :
January 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2022
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04093232
Start Date
January 1 2019
End Date
February 1 2022
Last Update
March 3 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
national Jewish health
Denver, Colorado, United States, 80206